Immunogenicity Studies of Plant-Produced SARS-CoV-2 Receptor Binding Domain-Based Subunit Vaccine Candidate with Different Adjuvant Formulations

Immunogenicity Studies of Plant-Produced SARS-CoV-2 Receptor Binding Domain-Based Subunit Vaccine Candidate with Different Adjuvant Formulations

Due to the rapid transmission of the coronavirus disease 2019 (COVID-19) causing serious public health problems and economic burden, the development of effective vaccines is a high priority for controlling the virus spread. Our group has previously demonstrated that the plant-produced receptor-bindi...

Full description

Bibliographic Details
Main Authors: Konlavat Siriwattananon, Suwimon Manopwisedjaroen, Balamurugan Shanmugaraj, Eakachai Prompetchara, Chutitorn Ketloy, Supranee Buranapraditkun, Kittipan Tharakhet, Papatsara Kaewpang, Kiat Ruxrungtham, Arunee Thitithanyanont, Waranyoo Phoolcharoen
Format: Article
Language:English
Published: MDPI AG 2021-07-01
Series:Vaccines
Subjects:
adjuvant
COVID-19
SARS-CoV-2
receptor-binding domain
plant-based vaccine
subunit vaccine
Online Access:https://www.mdpi.com/2076-393X/9/7/744

Internet

https://www.mdpi.com/2076-393X/9/7/744

Similar Items